BlackRock’s Dimension Therapeutics, Inc DMTX Stock Holding History

BlackRock’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-32,570	Closed	-$196K	–	5134
2017 Q3	$196K	Sell	32,570 -25,508	-44%	-$66.1K	﹤0.01%	4230
2017 Q2	$84K	Sell	58,078 -495,820	-90%	-$674K	﹤0.01%	4435
2017 Q1	$969K	Buy	553,898 +548,577	+10,310%	+$1.45M	﹤0.01%	3822
2016 Q4	$23K	Hold	5,321	–	–	﹤0.01%	3225
2016 Q3	$43K	Hold	5,321	–	–	﹤0.01%	3040
2016 Q2	$32K	Buy	5,321 +5,207	+4,568%	+$39.6K	﹤0.01%	3118
2016 Q1	$1K	Buy	+114	New	+$898	﹤0.01%	3628

BlackRock's DMTX Position: Q4 2017 in Review

BlackRock sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 32,570 shares — an estimated $196K sold.

BlackRock first reported a position in DMTX in Q1 2016 and held it in 7 quarters. The position peaked at $969K in Q1 2017. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

BlackRock reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
BlackRock sold 32,570 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $196K.
BlackRock first reported a position in Dimension Therapeutics, Inc in Q1 2016 and held it in 7 quarters.
BlackRock's Dimension Therapeutics, Inc position peaked at $969K in Q1 2017.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.